Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities
In this cross-sectional study, the proportion of SUDTFs offering MAUD increased from 2017 to 2021, but growth then plateaued. Policies supporting the expansion of MAUD-providing facilities, particularly in underserved counties, may be needed to address persistent gaps in access.
Authors
- Joshua Breslau (ORCID: https://orcid.org/0000-0002-1194-4643)
- Aaron Kofner (ORCID: https://orcid.org/0000-0001-6980-1218)
- Ensheng Dong (ORCID: https://orcid.org/0000-0002-9785-5739)
- Yuji Mizushima (ORCID: https://orcid.org/0000-0002-3481-7938)
- Abby Burnett
- Hao Yu (ORCID: https://orcid.org/0000-0003-4837-2324)
- Bradley D. Stein (ORCID: https://orcid.org/0000-0002-8868-8887)
- Fang Zhang
- Ryan K. McBain
- Jonathan Cantor
Institutions
- Brigham and Women's Hospital (US)
- RAND Corporation (US)
- Harvard University (US)
- RAND School of Public Policy (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.51563
- Citations
- 1
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 31.52
Funders
- Pfizer
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Mental Health
- National Institute of Nursing Research
- National Institute on Minority Health and Health Disparities